Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reprogramming of Lipid Metabolism in Lung Cancer: An Overview with Focus on EGFR-Mutated Non-Small Cell Lung Cancer
Kamal Eltayeb, Silvia La Monica, Marcello Tiseo, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 413-413
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

The strategic roles of four enzymes in the interconnection between metabolism and oncogene activation in non-small cell lung cancer: Therapeutic implications
Philippe Icard, Luca Simula, Ludovic Fournel, et al.
Drug Resistance Updates (2022) Vol. 63, pp. 100852-100852
Open Access | Times Cited: 39
Lipid alterations play a role in the integration of PD-1/PD-L1 inhibitors and anlotinib for the treatment of advanced non–small-cell lung cancer
Li Liu, Shuo Zhang, Haiyan Yang, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Lipid Levels and Lung Cancer Risk: Findings from the Taiwan National Data Systems from 2012 to 2018
Jung-Yueh Chen, Nai-Hui Chi, Ho-Sheng Lee, et al.
Journal of Epidemiology and Global Health (2025) Vol. 15, Iss. 1
Open Access
MiRNAs in Lung Cancer: Diagnostic, Prognostic, and Therapeutic Potential
Javaid Ahmad Wani, Sabhiya Majid, Zuha Imtiyaz, et al.
Diagnostics (2022) Vol. 12, Iss. 7, pp. 1610-1610
Open Access | Times Cited: 22
Identification and exploration of quinazoline-1,2,3-triazole inhibitors targeting EGFR in lung cancer
Sunil Kumar, Sounok Sengupta, Iqra Ali, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 21, pp. 11353-11372
Closed Access | Times Cited: 15
AMPK: an energy sensor for Non-small cell lung cancer progression and treatment
Zhengxiang Zhong, Xuyan Wang, Ying Pan, et al.
Pharmacological Research (2025), pp. 107592-107592
Open Access
Modeling and Interpretability Study of the Structure–Activity Relationship for Multigeneration EGFR Inhibitors
Zhiqi Sun, Donghui Huo, Jiangyu Guo, et al.
ACS Omega (2025)
Open Access
Identify metabolism-related genes IDO1, ALDH2, NCOA2, SLC7A5, SLC3A2, LDHB, and HPRT1 as potential prognostic markers and correlate with immune infiltrates in head and neck squamous cell carcinoma
Ce Li, Shuai Chen, Wenming Jia, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Targeted metabolomic profiling as a tool for diagnostics of patients with non-small-cell lung cancer
Ksenia M. Shestakova, Natalia E. Moskaleva, Andrey A. Boldin, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
Phytochemicals Target Multiple Metabolic Pathways in Cancer
Oleg Shuvalov, Yulia Kirdeeva, Alexandra Daks, et al.
Antioxidants (2023) Vol. 12, Iss. 11, pp. 2012-2012
Open Access | Times Cited: 9
Reovirus uses temporospatial compartmentalization to orchestrate core versus outercapsid assembly
Justine Kniert, Theodore dos Santos, Heather E. Eaton, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 9, pp. e1010641-e1010641
Open Access | Times Cited: 15
Stearoyl-CoA Desaturases1 Accelerates Non-Small Cell Lung Cancer Metastasis by Promoting Aromatase Expression to Improve Estrogen Synthesis
Jiaping Chen, Yangwei Wang, Wangyang Meng, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6826-6826
Open Access | Times Cited: 8
Surgical site wound infection and wound pain after video‐assisted thoracoscopy in patients with lung cancer: A meta‐analysis
Zhou Jian-hua, Zhiguo Ren, Xiwen Gao, et al.
International Wound Journal (2023) Vol. 20, Iss. 9, pp. 3898-3905
Open Access | Times Cited: 7
Inside anticancer therapy resistance and metastasis. Focus on CD36
Ioana Maria Lambrescu, Gisela Găină, Laura Cristina Ceafalan, et al.
Journal of Cancer (2024) Vol. 15, Iss. 6, pp. 1675-1686
Open Access | Times Cited: 2
Cisplatin‐resistance induces lung squamous carcinoma cell growth by nicotine‐mediated α7nAchR/HDAC1/Cyclin D1/pRb cell cycle activation
Leh Rao, Dan Guo, Jia‐Ping Wu
Cell Biochemistry and Function (2024) Vol. 42, Iss. 2
Open Access | Times Cited: 2
Sarcoidosis and Non-small Cell Lung Cancer: Expression of miR-145, miR-301, and miR-449
Negin Khosravi, Abdolreza Mohamadnia, Changiz Ahmadi Zadeh, et al.
Biomedical and Biotechnology Research Journal (BBRJ) (2024) Vol. 8, Iss. 4, pp. 517-523
Open Access | Times Cited: 2
Fatty acid metabolism and radiation-induced anti-tumor immunity
Mara De Martino, Camille Daviaud, Edgar Hajjar, et al.
International review of cell and molecular biology (2023), pp. 121-141
Closed Access | Times Cited: 5
An ingenious electrochemical aptasensor for detection of CYFRA 21–1 based on dual-output toehold mediated strand displacement reaction
Jinzhi Liu, Mengyan Wang, Chi Zhang, et al.
Bioelectrochemistry (2022) Vol. 147, pp. 108203-108203
Closed Access | Times Cited: 8
Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models
Silvia La Monica, Federica Vacondio, Kamal Eltayeb, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Co-Expression Network Analysis Unveiled lncRNA-mRNA Links Correlated to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Resistance and/or Intermediate Epithelial-to-Mesenchymal Transition Phenotypes in a Human Non-Small Cell Lung Cancer Cellular Model System
Valentina Fustaino, Giuliana Papoff, Francesca Ruberti, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3863-3863
Open Access | Times Cited: 1
[Research Progress on Tumor Metabolic Biomarkers in Liquid Biopsy of Lung Cancer].
Shishi Zou, Ning Li, Tianyu Zhang, et al.
PubMed (2024) Vol. 27, Iss. 2, pp. 126-132
Closed Access | Times Cited: 1
Targeting metabolic reprogramming to overcome drug resistance in advanced bladder cancer: insights from gemcitabine‐ and cisplatin‐resistant models
Ichiro Kawahara, Hirofumi Yoshino, Wataru Fukumoto, et al.
Molecular Oncology (2024)
Open Access | Times Cited: 1
HIF-1α-HPRT1 axis promotes tumorigenesis and gefitinib resistance by enhancing purine metabolism in EGFR-mutant lung adenocarcinoma
Pengyu Geng, Fei Ye, Peng Dou, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 1
Insights into Metabolic Reprogramming in Tumor Evolution and Therapy
Ching‐Feng Chiu, Jonathan Jaime G. Guerrero, Ric Ryan H. Regalado, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3513-3513
Open Access | Times Cited: 1
Prognostic signature of lipid metabolism associated LncRNAs predict prognosis and treatment of lung adenocarcinoma
Jie Zhao, Guangjian Li, Guangqiang Zhao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top